Liranaftate
利拉萘酯
Report date: 2023/02/22 20:00:32
NME
Base Information
Drug NameLiranaftate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesTorii Pharmaceutical Co LtdCisen Pharmaceutical Co Ltd
Inactive CompaniesBeijing Lingrui Weiye Technology Co LtdBeijing Guolian Chenghui Medicine Technology Co Ltd
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksKEGG